Production (Stage)
Nika Pharmaceuticals, Inc.
NIKA
$0.6495
-$0.0004-0.06%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.10K | 2.10K | 1.40K | 7.50K | 24.50K |
| Total Receivables | -- | -- | -- | 200.50K | -- |
| Inventory | -- | -- | -- | 14.10K | 17.00K |
| Prepaid Expenses | 15.90K | 15.90K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 0.00 | -- |
| Total Current Assets | 35.00K | 17.90K | 1.40K | 222.10K | 41.50K |
|
|
|||||
| Total Current Assets | 35.00K | 17.90K | 1.40K | 222.10K | 41.50K |
| Net Property, Plant & Equipment | -- | -- | -- | 168.30K | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 0.00 | -- |
| Total Assets | 35.00K | 17.90K | 1.40K | 390.30K | 41.50K |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | 4.60K | 9.30K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 269.20K | 239.20K | 210.20K | 632.30K | 256.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 269.20K | 239.20K | 210.20K | 636.90K | 266.00K |
|
|
|||||
| Total Current Liabilities | 269.20K | 239.20K | 210.20K | 636.90K | 266.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 269.20K | 239.20K | 210.20K | 632.30K | 256.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 269.20K | 239.20K | 210.20K | 636.90K | 266.00K |
|
|
|||||
| Common Stock & APIC | 8.70M | 8.70M | 8.70M | 8.71M | 8.71M |
| Retained Earnings | -8.94M | -8.93M | -8.92M | -8.96M | -8.93M |
| Treasury Stock & Other | -- | -- | -- | 0.00 | -- |
| Total Common Equity | -235.70K | -222.70K | -210.30K | -248.10K | -225.50K |
|
|
|||||
| Preferred Stock Redeemable | 1.50K | 1.50K | 1.50K | 1.50K | 1.00K |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.50K | 1.50K | 1.50K | 1.50K | 1.00K |
|
|
|||||
| Total Common Equity | -235.70K | -222.70K | -210.30K | -248.10K | -225.50K |
| Total Preferred Equity | 1.50K | 1.50K | 1.50K | 1.50K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -234.20K | -221.20K | -208.80K | -246.60K | -224.50K |
|
|
|||||